Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents
Authors
Keywords
Nrf2, Chemosensitizing, Cholangiocarcinoma, Cisplatin, Antioxidant, Antiproliferation
Journal
TUMOR BIOLOGY
Volume 37, Issue 8, Pages 11495-11507
Publisher
Springer Nature
Online
2016-03-25
DOI
10.1007/s13277-016-5015-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells
- (2015) Papavee Samatiwat et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer
- (2014) Xiu-Feng Hu et al. Asian Pacific Journal of Cancer Prevention
- Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
- (2014) Ploypailin Aneknan et al. Asian Pacific Journal of Cancer Prevention
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in Thailand
- (2013) Kritiya Butthongkomvong et al. Asian Pacific Journal of Cancer Prevention
- Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
- (2013) P-P Liu et al. CELL DEATH AND DIFFERENTIATION
- NRF2 immunolocalization in human breast cancer patients as a prognostic factor
- (2013) Yoshiaki Onodera et al. ENDOCRINE-RELATED CANCER
- Glucose availability is a decisive factor for Nrf2-mediated gene expression
- (2013) Elke H. Heiss et al. Redox Biology
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
- (2012) Shahid A Khan et al. GUT
- Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin–binding phosphoprotein 50 in cholangiocarcinoma
- (2012) Ponlapat Yonglitthipagon et al. HUMAN PATHOLOGY
- Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents
- (2012) Sarinya Kongpetch et al. PLoS One
- Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer
- (2011) Xiangdong Ma et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non–Small-Cell Lung Cancer
- (2011) Haihong Yang et al. Clinical Lung Cancer
- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
- (2011) Adam Lister et al. Molecular Cancer
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Redox modulation and human bile duct cancer inhibition by curcumin
- (2010) Bunliang Suphim et al. FOOD AND CHEMICAL TOXICOLOGY
- Oxidative modification sensitizes mitochondrial apoptosis-inducing factor to calpain-mediated processing
- (2010) Erik Norberg et al. FREE RADICAL BIOLOGY AND MEDICINE
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells
- (2010) Benjaporn Buranrat WORLD JOURNAL OF GASTROENTEROLOGY
- p21WAF1/CIP1and cancer: A shifting paradigm?
- (2009) Andrei L. Gartel BIOFACTORS
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Nrf2 as a Master Redox Switch in Turning on the Cellular Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive Phytochemicals
- (2008) Young-Joon Surh et al. PLANTA MEDICA
- Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
- (2008) S.A. Khan et al. HPB
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started